Cargando…
Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain
BACKGROUND: Chemokine axis chemokine C-X-C motif ligand 12/C-X-C chemokine receptor type 4 (CXCL12/CXCR4) is an emerging pain modulator, but mechanisms for its involvement in neuropathic pain remain unclear. Here, we aimed to study whether CXCL12/CXCR4 axis modulated the development of neuropathic p...
Autores principales: | Luo, Xin, Tai, Wai L, Sun, Liting, Pan, Zhiqiang, Xia, Zhengyuan, Chung, Sookja K, Cheung, Chi Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956184/ https://www.ncbi.nlm.nih.gov/pubmed/27030717 http://dx.doi.org/10.1177/1744806916636385 |
Ejemplares similares
-
Central Administration of C-X-C Chemokine Receptor Type 4 Antagonist Alleviates the Development and Maintenance of Peripheral Neuropathic Pain in Mice
por: Luo, Xin, et al.
Publicado: (2014) -
miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis
por: Pan, Zhiqiang, et al.
Publicado: (2018) -
CXCL10 and CXCR3 in the Trigeminal Ganglion Contribute to Trigeminal Neuropathic Pain in Mice
por: Ju, Yuan-Yuan, et al.
Publicado: (2021) -
Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7
por: Goïta, Aïssata Aimée, et al.
Publicado: (2022) -
CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer
por: Guo, Jun-Chao, et al.
Publicado: (2016)